prialt
esteve pharmaceuticals gmbh - zikonotiid - injections, spinal; pain - valuvaigistid - zikonotiid on näidustatud raske, kroonilise valu raviks patsientidel, kes vajavad intratekaalset (it) analgeesiat.
thiotepa riemser
esteve pharmaceuticals gmbh - tiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastilised ained - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.
akynzeo
helsinn birex pharmaceuticals ltd - netupitant, palonosetron vesinikkloriid - vomiting; neoplasms; nausea; cancer - antiemeetikumid ja antinauseants, - akynzeo on näidatud täiskasvanute jaoks:ennetamine akuutsed ja hilisemad iiveldus ja oksendamine, mis on seotud väga emetogenic cisplatin põhineb vähi keemiaravi. ennetamine akuutsed ja hilisemad iiveldus ja oksendamine on seotud mõõdukalt emetogenic vähi keemiaravi.
dinalgen suukaudne lahus
laboratorios dr. esteve, s.a. - ketoprofeen - suukaudne lahus - 300mg 1ml 100ml 1tk; 300mg 1ml 500ml 1tk
dinalgen süstelahus
laboratorios dr. esteve, s.a. - ketoprofeen - süstelahus - 60mg 1ml 100ml 1tk; 60mg 1ml 250ml 10tk; 60mg 1ml 100ml 10tk
nodetrip (previously xeristar)
esteve pharmaceuticals, s.a. - duloksetiin - anxiety disorders; depressive disorder, major; diabetic neuropathies - psychoanaleptics, - ravi depressiooniga;ravi diabeetilise perifeerse neuropaatilise valu;ravi generaliseerunud ärevushäire;xeristar on näidustatud täiskasvanutel.
inbrija
acorda therapeutics ireland limited - levodopa - parkinsoni tõbi - parkinsoni tõve ravimid - inbrija on näidustatud vahelduva ravi episoodiline mootor kõikumisi (vÄlja episoodid) täiskasvanud patsientidel, kellel on parkinsoni tõve (pd) töödeldud koos levodopa/dopa-decarboxylase inhibiitor.
dafiro
novartis europharm limited - amlodipine, valsartan - hüpertensioon - reniini-angiotensiini süsteemi toimivad ained - essentsiaalse hüpertensiooni ravi. dafiro on näidustatud patsientidele, kelle vererõhk ei ole adekvaatselt kontrollitav kohta amlodipine või valsartan monotherapy.
jalra
novartis europharm limited - vildagliptiin - suhkurtõbi, tüüp 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ja 5. 1 erinevate kombinatsioonide kohta kättesaadavate andmete osas).
zomarist
novartis europharm limited - vildagliptin, metformiin vesinikkloriid - suhkurtõbi, tüüp 2 - diabeetis kasutatavad ravimid - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.